WHO ICTRP trial
Evaluation of the effect of ginger (Zintoma capsule) on mild cognitive…
IRCT20201228049868N2 · Iranian Registry of Clinical Trials (IRCT) · Recruiting
Key facts
| Trial ID | IRCT20201228049868N2 |
|---|---|
| Public title | Evaluation of the effect of ginger (Zintoma capsule) on mild cognitive impairment |
| Scientific title | Evaluation of the effect of Zingebir Officinale (Zintoma capsule) on improvement of symptoms in patients with mild cognitive impairment (MCI)-Randomized, double-blind clinical trial |
| Primary sponsor | Birjand University of Medical Sciences |
| Registry | Iranian Registry of Clinical Trials (IRCT) |
| Recruitment status | Recruiting |
| Study type | interventional |
| Phase | 3 |
| Countries | Iran (Islamic Republic of) |
| Conditions | MCI (mild cognitive impairment). Mild cognitive disorder;F06.7 |
| Interventions | Intervention 1: Intervention group: Zintoma capsules 250 mg three times a day for 2 months (Goldaru Pharmaceutical Company). Intervention 2: Control group: Zintoma placebo capsule 250 mg three times a day for 2 months (Goldaru… |
| Registration date | Oct 27, 2021 |
| Target size | 60 |
| Registry page | irct.behdasht.gov.ir |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: